Page last updated: 2024-11-05

trazodone and Diabetes Mellitus, Type 2

trazodone has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adaikan, PG1
Ng, SC1
Chan, C1
Ratnam, SS1

Other Studies

1 other study available for trazodone and Diabetes Mellitus, Type 2

ArticleYear
Oral trazodone in the treatment of total secondary impotence in a diabetic patient.
    British journal of urology, 1991, Volume: 68, Issue:2

    Topics: Administration, Oral; Diabetes Mellitus, Type 2; Erectile Dysfunction; Humans; Male; Middle Aged; Ti

1991